SOD1 and metabolic dysfunction-associated steatotic liver disease: Notably, our data reveal that DPS administration significantly attenuated hepatic MDA accumulation while enhancing SOD activity, suggesting its potent capacity to counteract the redox imbalance characteristic of NAFLD progression.